Press Releases Items Per Page 102550 News Category FinancialGeneral Year None202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Reports Third Quarter 2023 Financial Results Nov 07, 2023 Nektar to Announce Financial Results for the Third Quarter 2023 on Tuesday, November 7, 2023, After Close of U.S.-Based Financial Markets Oct 31, 2023 Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress Oct 13, 2023 Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy Oct 02, 2023 Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer Sep 27, 2023 Nektar Therapeutics Announces Promising New Data from Phase 1b Study of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Sep 13, 2023 Nektar Therapeutics to Host Virtual Investor & Analyst Event with Dermatology Experts on September 13th Sep 06, 2023 Nektar Therapeutics Reports Second Quarter 2023 Financial Results Aug 08, 2023 Nektar Announces Promising New and Corrected Rezpegaldesleukin Efficacy Data Which Were Previously Reported in 2022 and Incorrectly Calculated by Former Collaborator Eli Lilly & Company Aug 07, 2023 Nektar to Announce Financial Results for the Second Quarter 2023 on Tuesday, August 8, 2023, After Close of U.S.-Based Financial Markets Aug 01, 2023 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »